RACHEL SCULLIN: Open Payments
NPI 1396139978 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$138 in 4 payments from 4 companies in 2025. Trend: 2023 $164 · 2024 $205 · 2025 $138
Food & beverage: $138
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 1 | $64 |
| Averitas Pharma Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: GEMTESA, QUTENZA, QULIPTA, SHINGRIX.
Industry payments across TX — which companies pay providers there.
